Chronic Disease Management Research
Longitudinal remote monitoring with adaptive visit schedules, PRO driven interventions, and real world evidence generation.
Rethinking Chronic Disease Trials
Chronic disease trials span months to years, requiring sustained patient engagement and continuous data collection that traditional visit based models can't deliver. Vitruvian Shield transforms chronic disease research with always-on remote monitoring and adaptive trial designs.
From cardiovascular and metabolic disorders to respiratory and autoimmune conditions, our platform captures the full patient journey, not just snapshots taken during clinic visits, enabling richer safety data, more sensitive efficacy endpoints, and genuine real world evidence.
Chronic Disease-Specific Capabilities
Longitudinal Remote Monitoring
Continuous vital signs tracking over months and years, blood pressure trends, glucose variability, respiratory function, weight changes, with automated adherence monitoring and gap detection.
Adaptive Visit Schedules
Dynamic visit scheduling that adjusts based on patient health status and study milestones. Reduce unnecessary visits while ensuring critical assessments aren't missed.
PRO-Driven Interventions
Patient-reported outcome data triggers clinical workflows automatically. Worsening symptom scores initiate investigator alerts, protocol-specified interventions, and safety reporting.
Real World Evidence Generation
Structured, continuous data collection generates regulatory-grade real world evidence. Support for pragmatic trial designs, registries, and post market surveillance studies.
Medication Adherence Tracking
Integration with smart pill bottles, dosing reminders, and patient reported medication logs. Correlate adherence patterns with clinical outcomes and treatment response.
Cardiovascular & Metabolic Modules
Pre configured workflows for hypertension, diabetes, heart failure, and NASH trials. Validated endpoint definitions, device-specific reference ranges, and indication-specific PRO instruments.
Study in Development
Remote cardiology monitoring programme in active partnership development.
VS-CARDIO-CH-DEV
Swiss Cardiology Remote Monitoring Programme
Remote cardiology monitoring programme in active partnership development with a Swiss academic cardiology center. Combines Analog Devices VSM Watch and Corsano CardioWatch 287B for continuous cardiovascular monitoring.
- Study Identifier
- In preparation
- Planned Enrollment
- To be confirmed
- Per-Patient Duration
- Longitudinal — to be confirmed
- Instruments & Devices
- Analog Devices VSM Watch, Corsano CardioWatch 287B
- Clinical Setting
- Swiss academic cardiology center (name withheld pending written publication consent).
- Timeline
- Activation target Q2 2026, subject to partnership finalisation.
Partnership details will be updated as written consent is secured. No clinical site is named publicly on this page until consent is in place.
Ready to Modernize Your Clinical Trials?
Join leading sponsors, CROs, and research sites using Vitruvian Shield to run faster, smarter, and more compliant trials.
Or contact our team for a personalized walkthrough.